博迅生物
(920504)
| 流通市值：2.69亿 | | | 总市值：7.07亿 |
| 流通股本：1651.09万 | | | 总股本：4333.31万 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 19,519,822.71 | 20,076,218.34 | 33,037,871.05 | 75,724,878.33 |
| 交易性金融资产 | 56,043,346.8 | 64,037,067.93 | 59,994,184.49 | 35,162,694.96 |
| 应收票据及应收账款 | 29,924,040.62 | 23,978,873.3 | 21,746,080.61 | 9,662,371.56 |
| 其中：应收票据 | 4,600,182 | 3,707,271.21 | 4,782,966.42 | 7,503,575.08 |
| 应收账款 | 25,323,858.62 | 20,271,602.09 | 16,963,114.19 | 2,158,796.48 |
| 应收款项融资 | 936,939.35 | 2,090,488.2 | 480,901.46 | 4,050,168.68 |
| 预付款项 | 2,190,976.13 | 2,002,820 | 1,554,681.61 | 1,159,783.09 |
| 其他应收款合计 | 117,441.74 | 131,981.55 | 191,864 | 102,493.16 |
| 存货 | 40,484,586.99 | 30,363,524.94 | 31,355,240.53 | 30,543,462.33 |
| 一年内到期的非流动资产 | 802,373.44 | 11,452,516.51 | 11,965,837.46 | 11,913,273.71 |
| 其他流动资产 | 16,745,803.74 | 15,360,287.1 | 3,631,063.6 | 3,358,514.55 |
| 流动资产合计 | 166,765,331.52 | 169,493,777.87 | 163,957,724.81 | 171,677,640.37 |
| 非流动资产: | | | | |
| 长期应收款 | 15,511,280.79 | 14,933,193.42 | 14,813,969.03 | 14,695,622.42 |
| 固定资产 | 23,535,990.78 | 24,286,705.57 | 24,255,467.67 | 24,938,182.73 |
| 在建工程 | 25,213,345.88 | 24,853,083.49 | 25,641,830.97 | 25,641,830.97 |
| 使用权资产 | 2,971,164.3 | 3,016,874.52 | 3,062,584.74 | 3,108,294.96 |
| 无形资产 | 9,190,740.44 | 9,315,120.38 | 9,442,302.74 | 9,549,418.04 |
| 长期待摊费用 | 6,685,349.04 | 7,069,677.32 | 7,471,153.34 | 7,872,629.39 |
| 递延所得税资产 | 3,711,454.84 | 3,530,519.27 | 3,547,064.39 | 3,788,148.7 |
| 其他非流动资产 | 10,031,561.64 | - | 10,139,808.23 | 10,088,027.4 |
| 非流动资产合计 | 96,850,887.71 | 87,005,173.97 | 98,374,181.11 | 99,682,154.61 |
| 资产总计 | 263,616,219.23 | 256,498,951.84 | 262,331,905.92 | 271,359,794.98 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 19,894,993.03 | 19,231,414.76 | 22,384,690.82 | 25,444,817.1 |
| 应付账款 | 19,894,993.03 | 19,231,414.76 | 22,384,690.82 | 25,444,817.1 |
| 合同负债 | 2,204,970.26 | 4,210,225.68 | 2,111,343.79 | 4,219,853.88 |
| 应付职工薪酬 | 2,529,702.91 | 2,324,436.14 | 2,283,166.74 | 5,490,571.38 |
| 应交税费 | 1,825,340.24 | 1,704,060.6 | 838,870.7 | 1,822,726.22 |
| 其他应付款合计 | 2,976,333.26 | 1,975,870.82 | 2,096,284.81 | 4,366,493.01 |
| 一年内到期的非流动负债 | 742,385.41 | 737,085.89 | 731,830.37 | 726,618.49 |
| 其他流动负债 | 4,994,982.88 | 2,880,672.52 | 5,212,266.15 | 4,140,807.37 |
| 流动负债合计 | 35,168,707.99 | 33,063,766.41 | 35,658,453.38 | 46,211,887.45 |
| 非流动负债: | | | | |
| 租赁负债 | 17,379,867.25 | 17,250,374.04 | 17,121,955.92 | 16,994,603.96 |
| 递延收益 | 1,433,339 | 1,533,338 | 1,633,337 | 1,733,336 |
| 递延所得税负债 | 1,554.27 | 5,560.19 | 16,239.56 | 13,669.52 |
| 非流动负债合计 | 18,814,760.52 | 18,789,272.23 | 18,771,532.48 | 18,741,609.48 |
| 负债合计 | 53,983,468.51 | 51,853,038.64 | 54,429,985.86 | 64,953,496.93 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 43,333,100 | 43,333,100 | 43,333,100 | 43,333,100 |
| 资本公积 | 114,590,131.66 | 114,590,131.66 | 114,590,131.66 | 114,590,131.66 |
| 盈余公积 | 20,213,544.1 | 20,213,544.1 | 20,213,544.1 | 20,213,544.1 |
| 未分配利润 | 31,495,974.96 | 26,509,137.44 | 29,765,144.3 | 28,269,522.29 |
| 归属于母公司股东权益合计 | 209,632,750.72 | 204,645,913.2 | 207,901,920.06 | 206,406,298.05 |
| 股东权益合计 | 209,632,750.72 | 204,645,913.2 | 207,901,920.06 | 206,406,298.05 |
| 负债和股东权益合计 | 263,616,219.23 | 256,498,951.84 | 262,331,905.92 | 271,359,794.98 |
| 公告日期 | 2026-10-29 | 2026-08-25 | 2026-04-28 | 2026-03-30 |
| 审计意见(境内) | | | | 标准无保留意见 |